Hypercalcemia, defined as a serum calcium level above the normal range of 9-10.5 mg/dL, requires prompt and appropriate intervention by nurses and healthcare providers to prevent serious complications such as cardiac arrhythmias and neuromuscular dysfunction. In this NCLEX practice question, the client's serum calcium level is critically elevated at 13.2 mg/dL, indicating the need for treatment aimed at lowering calcium levels. The medications commonly administered to manage hypercalcemia include phosphorus, calcitonin, and intravenous bisphosphonates. Phosphorus can help by binding with calcium to reduce elevated serum levels. Calcitonin acts to inhibit bone resorption, effectively decreasing calcium release from bones. Intravenous bisphosphonates are also used for longer-term control by inhibiting osteoclast-mediated bone resorption, making them a key option in cases of hypercalcemia associated with malignancy or other chronic conditions. It is important to avoid administration of vitamin D or IV calcium gluconate in this context, as these can further increase serum calcium and worsen the condition. Nursing students preparing for the NCLEX should understand the pharmacological rationale and clinical indications for each medication option when responding to lab results indicative of hypercalcemia. This practice question exemplifies the critical application of lab data analysis and clinical decision-making in nursing exams and real-world practice. Utilizing thousands of similar questions can enhance readiness and confidence for the NCLEX exam. Engaging with scenarios like this supports developing proficiency in safe medication administration and patient management, ultimately improving patient outcomes in hypercalcemic emergencies.